Neurological and neuropsychiatric manifestations and complications of SARS-CoV-2 infection: a narrative review and a case presentation in a previously healthy young white adult
DOI:
https://doi.org/10.22141/2224-0713.17.1.2021.226914Keywords:
COVID-19, SARS-CoV-2, acute myelitis, neurological presentations, neuropsychiatric presentations, complications, case report, reviewAbstract
Background. As the second wave of COVID-19 occurred, it has become clear that a novel coronavirus (SARS-CoV-2), which has consequently sparked a global pandemic, was evolved into wide-ranging multi-organ disease. However, neurological features of COVID-19 infection, especially in young previously healthy adults, have not been widely reported. We aimed to provide a narrative review of the neurological and neuropsychiatric manifestations and complications of SARS-CoV-2, supported with a clinical case presentation. Materials and methods. A comprehensive electronic literature search was performed on Scopus, PubMed, Embase, Cochrane database, World Health Organization database, Ovid, and Google Scholar in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines to identify the articles that discussed the neurological and neuropsychiatric presentations of SARS-CoV-2/COVID-19. The neurological manifestations and complications of COVID-19 are illustrated with the clinical case presentation in a previously healthy white young adult. Results and conclusions. Neurological and neuropsychiatric manifestations and complications of SARS-CoV-2 infection range from mild symptoms, such as headache, to catastrophic symptoms, including but not limited to delirium, manic episodes, schizophrenia, stroke, acute hemorrhagic necrotizing encephalopathy, transverse myelitis, encephalitis, meningitis, and Guillain-Barré syndrome. We provided a narrative review of the neurological and neuropsychiatric manifestations and complications of SARS-CoV-2 infection, illustrated with the clinical case presentation in a previously healthy white young adult.
Downloads
References
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020. Accessed at www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Johns Hopkins Coronavirus Resource Center. Accessed at https://coronavirus.jhu.edu/map.html
Ellul M.A., Benjamin L., Singh B. et al. Neurological associations of COVID-19. Lancet Neurol. 2020. 19 (9). 767-783. doi: 10.1016/S1474-4422(20)30221-0.
Yousfi N., Bragazzi N.L., Briki W., Zmijewski P., Chamari K. The COVID-19 pandemic: how to maintain a healthy immune system during the lockdown — a multidisciplinary approach with special focus on athletes. Biol. Sport. 2020. 37 (3). 211-216. doi: 10.5114/biolsport.2020.95125.
Rothwell J. The effects of COVID-19 on international labor markets: An update. Middle Class Memos (May 2020). Accessed: www.brookings.edu/research/the-effects-of-covid-19-on-international-labor-markets-anupdate.
Wu Y., Xu X., Chen Z. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020. 87. 18-22. doi: 10.1016/j.bbi.2020.03.031.
Phua J., Weng L., Ling L. et al. Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir. Med. 2020. 8 (5). 506-517. doi: 10.1016/S2213-2600(20)30161-2.
Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. 395. 1054-62. doi: 10.1016/S0140-6736(20)30566-3.
Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020. 382. 1708-20. doi: 10.1056/NEJMoa2002032.
Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020. 141. 1648-55. doi: 10.1161/CIRCULATIONAHA.120.046941.
Jin X., Lian J.S., Hu J.H., Gao J., Zheng L., Zhang Y.M. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020. 69. 1002-9. doi: 10.1136/gutjnl-2020-320926.
Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 27. e201017. doi: 10.1001/jamacardio.2020.1017.
Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020. 8. 475-81. doi: 10.1016/S2213-2600(20)30079-5.
Xu X.W., Wu X.X., Jiang X.G., Xu K.J., Ying L.J., Ma C.L. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020. 368. m606. doi: 10.1136/bmj.m606.
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 395. 497-506. doi: 10.1016/S0140-6736(20)30183-5.
Chen T., Wu D., Chen H., Yan W., Yang D., Chen G. et al. Clinical characteristics of 113 deceased patients with coronavirus di-sease 2019: retrospective study. BMJ. 2020. 368. m1091. doi: 10.1136/bmj.m1091.
Koralnik I.J., Tyler K.L. COVID-19: A Global Threat to the Nervous System. Ann. Neurol. 2020. 88. 1-11. doi: 10.1002/ana.25807.
Mao L., Jin H., Wang M. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020. 77 (6). 683-690. doi: 10.1001/jamaneurol.2020.1127.
Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020. 94. 55-58. doi: 10.1016/j.ijid.2020.03.062.
Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020 Aug. 296 (2). E119-E120. doi: 10.1148/radiol.2020201187.
Wong P.F., Craik S., Newman P., Makan A., Srinivasan K., Crawford E., Dev D., Moudgil H., Ahmad N. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin. Med. 2020. 20 (3). 293-294.
Zhao K., Huang J., Dai D. et al. Acute myelitis after SARS-CoV-2 infection: a case report. MedRxiv. 2020. doi: 10.1101/2020.03.16.20035105.
Sarma D., Bilello L.A. A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. Clin. Pract. Cases Emerg. Med. 2020. 4 (3). 321-323. doi: 10.5811/cpcem.2020.5.47937.
Munz M., Wessendorf S., Koretsis G. et al. Acute transverse myelitis after COVID-19 pneumonia. J. Neurol. 2020. 267 (8). 2196-2197. doi: 10.1007/s00415-020-09934-w.
Chow C.C.N., Magnussen J., Ip J., Su Y. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020. 13 (8). e236720. Published 2020 Aug 11. doi: 10.1136/bcr-2020-236720.
Valiuddin H., Skwirsk B., Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain Behav. Immun. Health. 2020. 5. 100091. doi: 10.1016/j.bbih.2020.100091.
Palahuta H.V., Yevtushenko S.K. A case of acute myelitis as a neurological complication of COVID-19. International Neurological Journal. 2020. 7 (16). 32-35. (in Ukrainian). doi: 10.22141/2224-0713.16.7.2020.218244.
Lechien J.R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 2020. 1. 11-22.
Asadi-Pooya A.A., Simani L. Central nervous system manifestations of COVID-19: A systematic review. J. Neurol Sci. 2020. 413. 116832. doi: 10.1016/j.jns.2020.116832.
Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020 May. 19 (5). 383-384. doi: 10.1016/S1474-4422(20)30109-5.
Gutiérrez-Ortiz C., Méndez-Guerrero A., Rodrigo-Rey S., San Pedro-Murillo E., Bermejo-Guerrero L., Gordo-Mañas R., de Aragón-Gómez F., Benito-León J. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 Aug 4. 95 (5). e601-e605. doi: 10.1212/WNL.0000000000009619.
Meegada S., Muppidi V., Wilkinson D.C. 3rd, Siddamreddy S., Katta S.K. Coronavirus Disease 2019-Induced Rhabdomyolysis. Cureus. 2020. 12 (8). e10123. doi: 10.7759/cureus.10123.
Guo Q., Zheng Y., Shi J. et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav. Immun. 2020. 88. 17-27. doi: 10.1016/j.bbi.2020.05.038.
Lu S., Wei N., Jiang J. et al. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. J. Affect. Disord. 2020. 277. 337-340. doi: 10.1016/j.jad.2020.08.031.
Banerjee D., Viswanath B. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian J. Psychiatr. 2020. 54. 102350. doi: 10.1016/j.ajp.2020.102350.
Fartushna O.Ye., Vinychuk S.M. Tranzytorni ishemichni ataky [Transient Ischemic Attacks]. Kyiv: PH “Avitsena”; 2014. 216 p. (in Ukrainian).
Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: A literature review. J. Clin. Neurosci. 2020 Jul. 77. 8-12. doi: 10.1016/j.jocn.2020.05.017. Epub 2020 May 6. PMID: 32409215; PMCID: PMC720036.
Hui D.S., Wong K.T., Antonio G.E., Tong M., Chan D.P., Sung J.J. Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med. J. 2009. 15. 21-23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 O.Yе. Fartushna, H.V. Palahuta, S.K. Yevtushenko
This work is licensed under a Creative Commons Attribution 4.0 International License.